A Dr.Scholls deal announcement in the next few weeks would be welcome. The FDA meetings I would assume will be, 'the meeting went well and look forward to hearing back from them.' I can't imagine it would be a long process afterward,as it's already cleared by them for knee and foot. Not clearing for other joints is like saying you can take Tylenol for knee and foot pain, but not for shoulder pain. It just doesn't make sense, especially considering it can be used over the eye.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.